First Horizon Advisors Inc. Sells 279 Shares of Cencora, Inc. (NYSE:COR)

First Horizon Advisors Inc. lowered its stake in shares of Cencora, Inc. (NYSE:COR) by 2.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,530 shares of the company’s stock after selling 279 shares during the quarter. First Horizon Advisors Inc.’s holdings in Cencora were worth $2,366,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Navellier & Associates Inc. boosted its position in Cencora by 3.8% during the 4th quarter. Navellier & Associates Inc. now owns 20,007 shares of the company’s stock valued at $4,495,000 after acquiring an additional 730 shares in the last quarter. Greystone Financial Group LLC lifted its stake in shares of Cencora by 3.0% in the 4th quarter. Greystone Financial Group LLC now owns 3,255 shares of the company’s stock valued at $731,000 after purchasing an additional 96 shares during the period. Passumpsic Savings Bank boosted its position in shares of Cencora by 1.5% during the fourth quarter. Passumpsic Savings Bank now owns 6,559 shares of the company’s stock valued at $1,474,000 after purchasing an additional 95 shares in the last quarter. Eubel Brady & Suttman Asset Management Inc. grew its stake in Cencora by 0.6% in the fourth quarter. Eubel Brady & Suttman Asset Management Inc. now owns 56,805 shares of the company’s stock worth $12,763,000 after purchasing an additional 331 shares during the period. Finally, Suncoast Equity Management raised its holdings in Cencora by 2.2% in the fourth quarter. Suncoast Equity Management now owns 27,407 shares of the company’s stock worth $6,158,000 after purchasing an additional 591 shares in the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Evercore ISI boosted their target price on shares of Cencora from $270.00 to $280.00 and gave the company an “outperform” rating in a report on Thursday, February 6th. Wells Fargo & Company boosted their price objective on shares of Cencora from $237.00 to $251.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 29th. UBS Group raised their target price on shares of Cencora from $275.00 to $285.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Barclays boosted their price target on Cencora from $263.00 to $290.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. Finally, JPMorgan Chase & Co. upped their price target on Cencora from $289.00 to $301.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $277.90.

Insider Activity

In other Cencora news, EVP Silvana Battaglia sold 1,678 shares of Cencora stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $228.72, for a total value of $383,792.16. Following the completion of the sale, the executive vice president now owns 20,329 shares of the company’s stock, valued at approximately $4,649,648.88. The trade was a 7.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 10.80% of the stock is owned by corporate insiders.

Cencora Stock Performance

COR stock opened at $241.47 on Monday. The stock has a market capitalization of $46.83 billion, a PE ratio of 34.35, a price-to-earnings-growth ratio of 1.31 and a beta of 0.49. The stock’s 50 day simple moving average is $239.52 and its 200 day simple moving average is $237.42. Cencora, Inc. has a 12-month low of $214.77 and a 12-month high of $262.26. The company has a current ratio of 0.92, a quick ratio of 0.54 and a debt-to-equity ratio of 16.40.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, February 5th. The company reported $3.73 EPS for the quarter, beating the consensus estimate of $3.50 by $0.23. Cencora had a return on equity of 328.62% and a net margin of 0.46%. As a group, research analysts forecast that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Friday, February 14th will be paid a $0.55 dividend. The ex-dividend date is Friday, February 14th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.91%. Cencora’s dividend payout ratio is presently 31.29%.

Cencora Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.